GENinCode (LON:GENI – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.
GENinCode Price Performance
Shares of GENI opened at GBX 0.72 on Wednesday. The firm has a market capitalization of £5.44 million, a PE ratio of -0.35 and a beta of 0.59. The company’s 50-day moving average is GBX 0.88 and its 200-day moving average is GBX 0.99. GENinCode has a fifty-two week low of GBX 0.64 and a fifty-two week high of GBX 4.90. The company has a debt-to-equity ratio of 117.74, a current ratio of 0.93 and a quick ratio of 15.88.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
Read More
- Five stocks we like better than GENinCode
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
